au3h-2026-03-15_04_32_05-bilasure-se-va-detailing-story.pdf
au3h-2026-03-15_04_32_05-bilasure-se-va-detailing-story.pdf
Doctor, Bilasure forty M provides statistically significant reduction of Total Symptom Score.
Week one: forty-six percent reduction.
Week two: seventy-two percent reduction.
Week four: eighty-six percent reduction.
Bilastine is well tolerated up to eighty milligrams daily and Montelukast provides significant efficacy in daytime and nighttime symptoms control.
The dosage of Bilasure forty M is one tablet daily, one hour before or two hours after food.
Bilastine has First line recommendation in Allergic rhinitis in ARIA.
Bilasure M has DUAL ACTION, which acts on the early and late phase of allergic reaction in Allergic rhinitis and concomitant Asthma.
Bilasure M in reducing Total Symptom Score is effective and comparable to Levocetirizine and Montelukast.
Doctor, efficacy of Bilasure twenty in reducing Total Nasal Symptom Score is
Comparable with Levocetirizine.
Superior than Fexofenadine.
Bilasure twenty has a favorable safety profile as it has
No QTc prolongation in humans.
No dosage adjustment in hepatic, renal, and elderly patients.
For up dosing in Chronic Spontaneous Urticaria recommend Bilasure forty, which contains Bilastine forty milligrams and has got Grade A recommendation for up dosing.
The dosage of Bilasure twenty and forty is one tablet daily, one hour before or two hours after food.